Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
4.08M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
988K
-
Shares change
-
+401K
-
Total reported value, excl. options
-
$23.1M
-
Value change
-
+$9.36M
-
Number of buys
-
11
-
Number of sells
-
-4
-
Price
-
$23.35
Significant Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) as of Q3 2025
24 filings reported holding VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share as of Q3 2025.
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 988K shares
of 4.08M outstanding shares and own 24.22% of the company stock.
Largest 10 shareholders include SAMSARA BIOCAPITAL, LLC (374K shares), FMR LLC (193K shares), Siren, L.L.C. (163K shares), BAKER BROS. ADVISORS LP (148K shares), VANGUARD GROUP INC (47K shares), GEODE CAPITAL MANAGEMENT, LLC (15.3K shares), NORTHERN TRUST CORP (14.1K shares), MILLENNIUM MANAGEMENT LLC (12.9K shares), Connective Capital Management, LLC (9.71K shares), and BlackRock, Inc. (4.94K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.